These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4706914)

  • 21. Effect of polybasic antibiotics and sulfaguanidine on absorption and excretion of cholesterol and bile salts.
    Eyssen H; Vanderhaeghe H; De Somer P
    Fed Proc; 1971; 30(6):1803-7. PubMed ID: 5124964
    [No Abstract]   [Full Text] [Related]  

  • 22. Physiology of bile acids in the ileum and colon.
    Eastwood MA
    Scott Med J; 1973 Sep; 18(5):142-4 passim. PubMed ID: 4584452
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantification of intestinal functions during fasting: estimations of bile salt turnover, fecal calcium and nitrogen excretions.
    Stanley MM
    Metabolism; 1970 Oct; 19(10):865-75. PubMed ID: 5506401
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantification of the binding tendencies of cholestyramine. 3. Rates of adsorption of conjugated bile salt anions onto cholestyramine as a function of added inorganic electrolyte concentration, temperature, and agitation intensity.
    Johns WH; Bates TR
    J Pharm Sci; 1970 Jun; 59(6):788-93. PubMed ID: 5423079
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological modification of lipoprotein metabolism.
    Shepherd J; Packard CJ
    Biochem Soc Trans; 1987 Apr; 15(2):199-201. PubMed ID: 3556260
    [No Abstract]   [Full Text] [Related]  

  • 26. rHDL administration increases reverse cholesterol transport in mice, but is not additive on top of ezetimibe or cholestyramine treatment.
    Maugeais C; Annema W; Blum D; Mary JL; Tietge UJ
    Atherosclerosis; 2013 Jul; 229(1):94-101. PubMed ID: 23725986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of antacids on the binding of bile salts.
    Cousar GD; Gadacz TR
    Arch Surg; 1984 Sep; 119(9):1018-20. PubMed ID: 6477113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of in vitro bile acid binding capacity and in vivo hypocholesteremic activity of cholestyramine.
    Whiteside CH; Fluckiger HB; Sarett HP
    Proc Soc Exp Biol Med; 1966 Jan; 121(1):153-6. PubMed ID: 5902919
    [No Abstract]   [Full Text] [Related]  

  • 29. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism.
    Grundy SM; Ahrens EH; Salen G
    J Lab Clin Med; 1971 Jul; 78(1):94-121. PubMed ID: 5569253
    [No Abstract]   [Full Text] [Related]  

  • 30. In vivo effect of bile salts and cholestyramine on intestinal anaerobic bacteria.
    Williams RC; Showalter R; Kern F
    Gastroenterology; 1975 Aug; 69(2):483-91. PubMed ID: 1150050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feeding rats diets containing cheno- or ursodeoxycholic acid or cholestyramine modifies intestinal uptake of glucose and lipids.
    Thomson AB; Keelan M
    Digestion; 1987; 38(3):160-70. PubMed ID: 3443226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cholestyramine and diet on hydroxylations in the biosynthesis and metabolism of bile acids.
    Johansson G
    Eur J Biochem; 1970 Dec; 17(2):292-5. PubMed ID: 5500398
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholestyramine treatment reduces postprandial but not fasting serum bile acid levels in humans.
    Angelin B; Björkhem I; Einarsson K; Ewerth S
    Gastroenterology; 1982 Nov; 83(5):1097-101. PubMed ID: 7117793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro binding of mixed micellar solutions of fatty acids and bile salts by cholestyramine.
    Hagerman LM; Julow DA; Schneider DL
    Proc Soc Exp Biol Med; 1973 May; 143(1):89-92. PubMed ID: 4703450
    [No Abstract]   [Full Text] [Related]  

  • 35. The interaction between cholestyramine and drugs.
    Gallo DG; Bailey KR; Sheffner AL
    Proc Soc Exp Biol Med; 1965 Oct; 120(1):60-5. PubMed ID: 5852732
    [No Abstract]   [Full Text] [Related]  

  • 36. Sequestering agents and bile salts.
    Lancet; 1970 Nov; 2(7681):1023-4. PubMed ID: 4098054
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of DEAE Sephadex on liver vitamin A of lactating rats and their offspring.
    Cecil HC; Harris SJ; Bitman J; Dryden LP
    J Nutr; 1973 Jan; 103(1):43-9. PubMed ID: 4682452
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of cholestyramine on the synthesis-ratio of cholic- and chenodeoxycholic acid in hamsters.
    Kempi V; van der Linden W
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):424-8. PubMed ID: 5566723
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of cholestyramine-induced bile acid depletion on the hepatobiliary transport of cholephilic organic anions in rats.
    Gregus Z; Fischer E; Varga F
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):311-22. PubMed ID: 7406609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bile acids of blood serum in patients with intrahepatic cholestasis and their change during the treatment with cholestyramine].
    Loginov AS; Amirov NSh; Kriukova LV; Iartseva AM
    Klin Med (Mosk); 1973 Dec; 51(12):57-61. PubMed ID: 4779022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.